NCEL (NewcelX) Other Current Payables: $0.00 Mil (As of Dec. 2025)


NCEL NewcelX Ltd NCEL
33 GF Score
Price $3.83
! 4 Warning Signs
View Full Analysis

What is NewcelX Other Current Payables?

NewcelX NCEL -0.52% 33 Other Current Payables is $0.00 Mil as of Dec. 2025. GuruFocus rates NCEL with a GF Score™ of 33/100. The stock has 4 warning signs investors should review.

NewcelX's Other Current Payables for the quarter that ended in Dec. 2025 was $0.00 Mil.

NewcelX's quarterly Other Current Payables increased from Dec. 2024 ($0.40 Mil) to Jun. 2025 ($0.66 Mil) but then declined from Jun. 2025 ($0.66 Mil) to Dec. 2025 ($0.00 Mil).

NewcelX's annual Other Current Payables increased from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.40 Mil) but then declined from Dec. 2024 ($0.40 Mil) to Dec. 2025 ($0.00 Mil).

NewcelX Other Current Payables Related Terms

NewcelX Other Current Payables Historical Data

* Premium members only.

The historical data trend for NewcelX's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NewcelX Other Current Payables Chart

NewcelX Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.65 0.36 0.00 0.40 0.00

NewcelX Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.16 0.40 0.66 0.00
NCEL
33GF Score
NewcelX Ltd NCEL
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NewcelX Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $0.00 Mil mean?
NewcelX (NCEL) has a Other Current Payables of $0.00 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on NewcelX and its competitors.
Is NewcelX's Other Current Payables too high?
NewcelX's current Other Current Payables is $0.00 Mil. Overall, NewcelX has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does NewcelX's Other Current Payables compare to LPCN and PTN?
NewcelX's Other Current Payables of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on NewcelX and its competitors. NewcelX's current Other Current Payables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NewcelX stock overvalued right now?
NewcelX (NCEL) has a current Other Current Payables of $0.00 Mil. The current Other Current Payables is $0.00 Mil. NewcelX's overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For NewcelX (NCEL), the current Other Current Payables is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NewcelX Business Description

Address Hohstrasse 1, Kloten, CHE, 8302
NewcelX Ltd is a clinical-stage biopharmaceutical company focused on developing transformative therapies. Built on a validated human pluripotent stem cell (hPSC) platform, the Company's main program, NCEL-101, is designed to restore functional insulin production through scalable, off-the-shelf cell replacement. It is advancing a comprehensive therapeutic approach for Type 1 Diabetes, integrating cell therapy, immune protection, and translational science, including a phase IIa clinical trial for the treatment of Amyotrophic Lateral Sclerosis (ALS) in the field of regenerative medicine, as well as the development of treatments for Central Nervous System (CNS) disorders, including Narcolepsy, utilizing its Doxa platform. Its products are Holistic, IsletRx, AstroRx, and the DOXA platform.
33GF Score

Get the complete analysis for NCEL

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.83
Price